Breaking news
Merck KGaA: $17bn 'Rolls Royce' Sigma-Aldrich to keep major St Louis site
The $17bn (€13.2bn) acquisition of Sigma-Aldrich is “not just a milestone but a quantum leap” for Merck KGaA, the firm says.
Archives for September 21, 2014
Ukraine still attracting Quintiles, PPD, Icon, Parexel and INC says study
Political instability in Ukraine has not diminished international drug industry desire to conduct clinical trials there according to a new report.
Pfizer and Irish port authorities working to stop API plant gathering dust
Pfizer is working with Irish authorities to avoid a repeat of a 2013 incident when dust produced from Cork harbour entered its nearby API facility.
Say ‘cheese’: database collects pill photos
The US National Institutes of Health (NIH) is collecting photos of pills and tablet in a database for use in apps to improve public safety.
TransCelerate hones in on two aspects of new risk-based monitoring methodology
TransCelerate’s new RBM (risk-based monitoring) methodology focuses on the use of technology and centralized monitoring to shift away from Source Data Verification (SDV) to risk-driven monitoring, according to two papers in the Drug Information...
Concerns raised over FDA’s informed consent draft guidance
The US FDA was flooded with comments on its draft guidance seeking to amend the informed consent process – with some saying the guidance will further confuse patients while others took issue with what the revisions didn’t include.
Telormedix granted 'most important patent ' for TLR agonist bladder cancer drug
Telormedix has been granted a European patent for increasing the solubility of its lead bladder cancer toll-like receptors (TLR) treatment Vesimune.